Semax + Cerebrolysin experience — Daniel R

I’m 32 and work as a senior backend engineer. I had a concussion at 19, and by my late twenties I started realizing that my focus had probably been getting worse for years. I was diagnosed with inattentive ADHD at 29. Medikinet helped, but I didn’t like the cardiovascular side effects or the rebound. Modafinil felt smoother, but it gave me constant low-level anxiety, so I started looking into other options.

Semax helped, especially at first. During weeks two to four, my focus was better, my mood felt lighter, and I was falling asleep more easily. It wasn’t dramatic or euphoric. It just felt like my brain was cooperating more than usual. The downside was that the effect gradually faded, and by the end of the eight weeks it felt much weaker.

Cerebrolysin felt more significant overall. I noticed the mental fog starting to lift during the first week, and later my sleep and work output improved too. The second cycle seemed to work faster than the first. At the same time, daily IM injections were a real hassle and required much more planning, supplies, and care than Semax.

I also had the Semax tested at an accredited lab, and it came back at 84% of the labeled concentration. That made me much more cautious about vendors. With an injectable product, I would only consider using it through a legitimate pharmacy route.

My takeaway is that both had value, but in very different ways. Semax was easy to use and gave me a noticeable short-term boost in focus and mood, but the effect clearly faded with continued use. Cerebrolysin felt more meaningful and longer-lasting, especially for mental clarity, sleep, and overall work performance, but the injections, sourcing, and sterility concerns made it a much bigger commitment.

I’d consider using both again, but only in cycles and with better tracking from day one. More than anything, the experience showed me how easy it is to fool yourself. Feeling better is not enough. You need clear metrics, consistent tracking, and a plan for when to stop. The peptide space would benefit from much more practical discussion about that, and much less miracle-or-scam hype.